KKR & Co. is exploring options including selling its controlling stake in India’s JB Chemicals & Pharmaceuticals Ltd. amid interest from potential buyers, according to people familiar with the matter.
The US private equity firm is looking to hire financial advisers to help evaluate a sale of its 53.8% stake in the Mumbai-based company, the people said, asking not to be identified as the matter is private. Other buyout firms and industry players have shown preliminary interest in buying KKR’s stake, the people said.
Shares of the company, which is known as JB Pharma, have climbed 68% in the past 12 months, valuing the firm at just over $3 billion.
Can’t stop reading? Read more
Blackstone explores launch of dedicated private credit secondaries strategy
Blackstone explores launch of dedicated private credit secondaries strategy Blackstone is...
Blue Owl and Koda Capital unlock US private credit access for Australian investors
Blue Owl and Koda Capital unlock US private credit access for Australian investors Blue Owl...
Orangewood backs major 7 Brew franchisee as brand continues rapid US expansion
Orangewood backs major 7 Brew franchisee as brand continues rapid US expansion Orangewood Partners...